Leadership and Governance
The Biomarkers Consortium brings together various partners to identify, develop and qualify potential biomarkers to improve drug development and regulatory decision-making.
Jump to
Executive Committee
The Biomarkers Consortium’s Cancer, Inflammation & Immunity, Metabolic Disorders and Neuroscience Steering Committees are responsible for identifying and moving forward promising pre-competitive biomarkers projects for implementation by the Biomarkers Consortium, as well as overseeing each individual project under its purview.
The members of each Steering Committee represent a variety of sectors, including academia, government, industry and not-for-profit/advocacy organizations, and are led by two co-chairs representing two of the following three sectors: academia, government or industry.
Cancer Steering Committee
- Gary Kelloff, M.D., NIH/NCI, (Co-Chair)
- Geoff Oxnard, M.D., Foundation Medicine (Co-Chair)
- Emmett Schmidt, M.D., Ph.D., Merck (Co-Chair)
- Alexandre Akoulitchev, Ph.D., Oxford Biodynamics
- Jeff Allen, Ph.D., Friends of Cancer Research
- Christopher Below, Ph.D., Biognosys
- Michelle Berny-Lang, Ph.D., NCI
- Donald A. Berry, Ph.D., MD Anderson Cancer Center
- Vikram Bhadrasain, M.D., NCI
- Jonathan Blackburn, Ph.D., Sengenics
- Mohan Bolisetty, Ph.D., Bristol-Meyers Squibb
- Gary Borzillo, Ph.D., Janssen
- Anita Boyapati, Ph.D., Regeneron
- Claudio Carini, Ph.D. Kings College London
- Hearn Jay Cho, M.D., Ph.D., The Multiple Myeloma Research Foundation
- Caroline Chung, M.D., MD Anderson (QIBA-RSNA)
- Steven Cole, NCI
- Cecile Combeau, Ph.D., Sanofi
- Ellie Corigliano, Ph.D., GlaxoSmithKline
- Adam Corner, BioRad
- Craig Cummings, Ph.D., Genentech
- Emmanuelle di Tomaso, Ph.D., Bayer
- DeAunne Denmark, M.D., Ph.D., Somalogic
- Michelle Douglas, Ph.D., Genentech
- Jeff Ecsedy, Ph.D., Ikena Oncology
- Michael Espey, Ph.D., NCI
- Steven Gendreau, Ph.D., Genentech
- Giuseppe Giaccone, M.D., Ph.D., Amgen
- Charlie Glaus, Ph.D., Bayer
- Ida Grundberg, Ph.D., Olink
- Stanley R. Hamilton, M.D., City of Hope National Medical Center
- Sean Hanlon, Ph.D., NCI
- Lyndsay Harris, M.D., NCI
- James Hnatyszyn, Ph.D., Seattle Genetics, Inc.
- Steffan Ho, M.D., Ph.D., Pfizer
- Rob Iannone, M.D., Jazz Pharmaceuticals
- Peter Intile, SITC
- Taylor Jensen, Ph.D., LabCorp
- John Jessup, M.D., Institute for Bioscience and Biotechnology Research
- Maria Jure-Kunkel, Ph.D., Genmab US, Inc.
- Jayaprakash Karkera, Ph.D., GlaxoSmithKline
- Morten Karsdal, Ph.D., Nordic Bioscience
- Ilan (Lanny) Kirsch, M.D., Adaptive Biotechnologies
- Klaus Lindpaintner, M.D., M.P.H., InterVennn Biosciences
- Tracy Lively, Ph.D., NIH/NCI
- Kate Lyden, Ph.D., VivoSense
- Daniel Maslyar, M.D., Alector
- Derek McCartney, M.S., Biognosys
- Robert McCormack, Ph.D.
- Mark Messenbaugh, J.D., SomaLogic
- Jen Mills, Ph.D., Foundation Medicine
- Mike Montalto, Ph.D., PathAI
- Helen Moore, Ph.D., NIH/NCI
- Larry Nagahara, Ph.D., John’s Hopkins University
- Tanya Nguyen, Ph.D., Sapient Bioanalytics
- Michael O’Neal, M.D., BioClinica, Inc.
- Mariaelena Occhipinti, Ph.D., Radiomics
- Malhar Patel, M.D., Rhino Health
- Snehal Patel, Ph.D., Association for Molecular Pathology
- Reena Philip, Ph.D., FDA/OCE
- Vladimir Popov, Ph.D., FNLCR/NCI
- Scott Knowles Pruitt, M.D., Ph.D., Merck
- Elizabeth Punnoose, Ph.D., Genentech
- Gregory Reaman, M.D., FDA/CDER
- Anita Reddy, Ph.D., Amgen
- Henry Rodriguez, Ph.D., NIH/NCI
- Vanessa Rodrik-Outmezguine, Ph.D., Eli Lilly & Company
- Marijana Rucevic, Ph.D., Olink Proteomics
- Amy Kate Sasser, Ph.D., Genmab US, Inc.
- Julie Schneider Ph.D., FDA/OCE
- Lawrence Schwartz, M.D., Memorial Sloan Kettering
- Maggie Scully, Ph.D.,Frederick Natl. Lab. For Cancer Research
- Alex Snyder, Ph.D., Generate Biomedicines (SITC)
- Magadelena Thurin, Ph.D., NIH/NCI
- Raoul Tibes, M.D., Ph.D., AstraZeneca
- Peter Ujhazy, M.D., Ph.D., NIH/NCI
- Tamar Uziel, Ph.D., AbbVie
- Megann Vaughn, M.B.A., LabCorp
- Wim Vos. Ph.D., Radiomics
- Sean Walsh, Ph.D., Radiomics
- Tony Wagner, Ph.D., Jazz Pharmaceuticals
- Ilan Wapinski, Ph.D., PathAI
- Christine Ward, Ph.D., Takeda Pharmaceuticals International, Inc.
- Mike Ward, Ph.D., Alector
- Lisa Williams, Ph.D., Foundation Medicine
- Mickey Williams, Ph.D., NIH/NCI
- Philip Worboys, Ph.D., Sapient Bioanalytics
- Lan Xu, Ph.D., Ikena Oncology
Inflammation & Immunity Steering Committee
- Carolyn Cuff, Ph.D., Janssen (Co-Chair)
- David Fox, M.D., University of Michigan (Co-Chair)
- Alexandre Akoulitchev, M.A., Ph.D., Oxford Biodynamics
- Tara Altepeter, M.D., FDA/CDER
- Niyanna Barron, M.B.A., OLINK
- Anne-Christine Bay-Jensen, Ph.D., Nordic Biosciences A/S
- Robert Benschop, Ph.D., Eli Lilly
- Maria Bettinotti, Ph.D., Association of Molecular Pathology (AMP)
- Jonathan Blackburn, Ph.D., Sengenics
- Alex Blasky, Ph.D., SomaLogic
- Mathias Blom, M.D., Ph.D., Rhino Health
- Preethi Chander, Ph.D., NIDCR/NIH
- Carol Feghali-Bostwick, Ph.D., National Scleroderma Foundation
- Chao Jiang, Ph.D., NIAID/NIH
- Kelly Chun, Ph.D., LabCorp
- Sahar Dawisha, M.D., FDA/CDRH
- Betty Diamond, Ph.D., Feinstein Institute
- Renee Donahue, Ph.D., NIH/NCI
- Tom Esch, Ph.D., NIAID/NIH
- Thomas Fuerst, Ph.D., BioClinica
- Heath Guay, Ph.D., AbbVie
- Kathy Hammitt, M.A., Sjogren's Foundation
- Caren Heller, M.D., MBA, Crohn's & Colitis Foundation of America
- Andrea Hooper, Ph.D, Regeneron
- Julie Huang, Ph.D., Alector
- Robert Iannone, M.D., Jazz Pharmaceuticals
- Kathy Jung, Ph.D., NIH/NIAA
- Ernst Kriehuber, M.D., UCB
- David Martin, M.D., Pfizer
- Afsaneh Mozaffarian, Gilead
- Bruce McManus, M.D., Ph.D., University of British Columbia
- Sumanta Mukherjee, Ph.D., GlaxoSmithKline
- Maik Muller, Ph.D., Biognosys
- Nikolay Nikolov, M.D., FDA/CDER
- Mariaelena Occhipinti, M.D., Ph.D., Radiomics
- Heiyoung Park, Ph.D., NIAMS/NIH
- Jane Parnes, M.D., Amgen
- Brian Porter, M.D., Ph.D., M.P.H., M.B.A., Novartis
- Barbara Radziszewska, Ph.D., M.P.H., NIH/NIA
- Deepak Rajpal, Ph.D., Sanofi
- John Reveille, M.D., University of Texas Health Science Center (Houston)
- Lisa Rider, M.D., NIH/NIEHS
- Jonathan Robbins, M.D., Ph.D., Merck
- Jane Salmon, M.D., Hospital for Special Surgery
- Maggie Scully, Ph.D., Frederick National Laboratory for Cancer Research
- Susana A. Serrate-Sztein, M.D., NIH/NIAMS
- Glennda Smithson, Ph.D., Takeda
- Lisa Spain, Ph.D., NIH / NIDDK
- Emily Boyd Stormoen, Arthritis National Research Foundation
- Michael Townsend, Ph.D., Genentech
- Maria Vassileva, Ph.D., Arthritis Foundation
- Sudha Visvanathan, Ph.D., Boehringer Ingelheim
- Andrea Wagenfeld, Ph.D., Bayer
- Tony Wagner, Ph.D., Jazz Pharmaceuticals
- Ilan Wapinski, Ph.D., PathAI
- Michael Weisman, M.D., Cedars-Sinai Medical Center
- Mary Wheatley, National Scleroderma Foundation
- Michael Whitfield, Ph.D., Dartmouth Geisel School of Medicine
- Philip Worboys, Ph.D., Sapient Bioanalytics
Metabolic Disorders Steering Committee
- Henry Burch, M.D., NIH/NIDDK (Co-Chair)
- Roberto Calle, M.D., Regeneron (Co-Chair)
- Vandana Sachdev, M.D.. NIH/NHLBI (Co-Chair)
- Nigel Beaton, Ph.D., Biognosys
- Stan Belkowski, Ph.D., Janssen
- Javed Butler, MD, University of Mississippi
- Joel Dalrymple, Ph.D., Somalogic
- Jay M Edelberg, M.D., Ph.D., Prolaio
- Samuel Engel, M.D., Merck
- Klaus Engelke, Ph.D., BioClinica
- Mike Espey, PhD, NCI
- Josh Fessel, M.D., Ph.D., NCATS
- Christian Friedrich, Bayer
- Gopi Ganji, Ph.D., GlaxoSmithKline
- Chelsea Gordon, MBA, Verily
- Chris Hartshorn, PhD, NCI
- Claude Hughes, M.D., Ph.D., IQVIA
- Lyndon Joseph, Ph.D., NIH/NIA
- Satya Karnik, Ph.D., Regeneron
- Morten Karsdal, Ph.D., M.Sc., mMBA, Nordic Bioscience A/S
- Makoto Kashiwa, Ph.D., Astellas
- Helina Kassahun, M.D., Amgen
- Keith Kaufman, M.D., Merck
- Young S. Kim, Ph.D., NIH/NCI
- Kathy Landschulz, Ph.D., Covance
- Olof Dahlqvist Leinhard, Ph.D., AMRA Medical
- Maria Chiara Magnone, Ph.D., Janssen
- Mark Messenbaugh, JD, Somalogic
- Mike Montalto, Ph.D., PathAI
- Antonella Napolitano, M.D., Ph.D., GlaxoSmithKline
- Tanya Nguyen, Ph.D., Sapient Bioanalytics
- Afshin Parsa, M.D., MPH, NIH/NIDDK
- Malhar Patel, M.D., Rhino Health
- Aaron Pawlyk, PhD, NCHID
- Sven Reimann, Ph.D., Bayer
- Jim Revkin, M.D., Ph.D., Pfizer
- Anthony Samir M.D., MGH
- Arun Sanyal, M.D., VCU
- Sudha Shankar, M.D., AstraZeneca
- Pothur Srinivas, Ph.D., NIH/NHLBI
- Elizabeth Stafford, Ph.D., FDA/CDRH
- Paresh Thakker, Ph.D., Takeda
- Melissa Thomas, M.D., Ph.D., Eli Lilly
- Moises Torres-Gonzalez, Ph.D., National Dairy Council
- Sharat Varma, Ph.D., Novo Nordisk
- Megann Vaughn, M.B.A., LabCorp
- David R. Vera, Ph.D., University of California, San Diego
- Tony Wagner, PhD, Jazz Pharmaceuticals
- Sean Walsh, Ph.D., Radiomics
- Mike Ward, Ph.D., Alector
Neuroscience Steering Committee
- Linda Brady, Ph.D., NIH/NIMH (Co-Chair)
- Hartmuth Kolb, Ph.D., Janssen (Co-Chair)
- William Potter, M.D., Ph.D., NIH/NIMH (Co-Chair Emeritus)
- Alexandre Akoulitchev, M.A., Ph.D., Oxford Biodynamics
- David Anderson, Ph.D., Clinical ink
- Anthony Bannon, Ph.D., AbbVie
- Daniel Barboriak, M.D., Radiological Society of North America
- Wade Berrettini, M.D., Ph.D., UPenn
- Nicole Bjorklund, Ph.D., Alzheimer's Drug Discovery Foundation
- Jonathan Blackburn, Ph.D., MASSAf, Sengenics
- Mathias Blom, M.D., Ph.D., Rhino Health
- Silvana Borges, M.D., FDA
- Diane Bovenkamp, Ph.D., BrightFocus Foundation
- Danielle Boyce, The Robert Packard Center for ALS Research at Johns Hopkins
- Brian Campbell, Ph.D., Sage Therapeutics
- Maria Carrillo, Ph.D., Alzheimer's Association
- Susan Catalano, Ph.D., Cognition Therapeutics
- Caroline Cohen, Ph.D., Sanofi
- Susan Croll, Ph.D., Regeneron
- Francesca De Simone, Ph.D., Fujirebio
- Ken Duckworth, M.D., NAMI
- Rebecca Edelmayer, Ph.D., Alzheimer's Association
- Rianne Esquivel, Ph.D., Fujirebio
- Yuehan Feng, Ph.D., Biognosys
- Howard Fillit, M.D., Alzheimer's Drug Discovery Foundation
- Thomas Finn, Ph.D., FDA
- Bernard Fischer, M.D., FDA/CDER
- Just Genius, M.D., UCB
- Danielle Graham, Ph.D., Biogen
- Ida Grudenberg, Ph.D., Olink Proteomics
- Lyn Jakeman, Ph.D., NINDS
- Katherine Jung, Ph.D., NIH/NIAAA
- Morten Karsdal, Ph.D., M.Sc., mMBA, Nordic Bioscience A/S
- Walter J. Koroshetz, M.D., NIH/NINDS
- Frank Lebeda, Ph.D., US Military
- Kristina Malzbender, Gates Ventures
- Eliezer Masliah, Ph.D., NIH/NIA
- Bradley Miller, M.D., Ph.D., Eli Lilly
- David Millis, M.D., M.B.A., Ph.D., FDA/CDER
- Laura Mitic, Ph.D., The Bluefield Project to Cure FTD
- Jose Luis Molinuevo, M.D., Ph.D., Barcelona Beta Brain Research Center
- Mike Montalto, Ph.D., PathAI
- Tanya Nguyen, Ph.D., Sapient Bioanalytics
- Prodromos Parasoglou, Ph.D., Regeneron
- Lovingly Park, Ph.D., Alector
- Rodney Pearlman, Ph.D., The Bluefield Project to Cure FTD
- Mary Ann Pelleymounter, Ph.D., NIH/NINDS
- Chris Petropoulos, LabCorp
- Niels Plath, Ph.D., Lundbeck
- Josh Porter, Olink Proteomics
- Kurt Rasmussen, Ph.D., NIH/NIDA
- Sounder Regunathan, Ph.D., NIH/NIAAA
- Cristina Sampaio, M.D., Ph.D., CHDI Foundation
- Steve Sands, Ph.D., Amgen
- Bob Schafer, Ph.D., Lumos Labs
- Nina Schor, Ph.D., NIH/NINDS
- Howard Schulman, Ph.D., Allosteros Therapeutics
- Lamya Shihabuddin, Ph.D., Sanofi
- Daniel Smith, Ph.D., Alkermes
- Sean Smith, Ph.D., Merck
- Arie Struyk, M.D., Ph.D., Merck
- Joyce Suhy, Ph.D., BioClinica
- Nadine Tatton, Ph.D., The Association for Frontotemporal Degeneration
- Johannes Tauscher, M.D., Takeda
- Chris Turck, Ph.D., Max Planck Institute of Psychiatry
- Eugeen Vanmechelen, Ph.D., ADx Neurosciences
- Sean Walsh, Ph.D., Radiomics
- Chris Weber, Ph.D., Alzheimer's Association
- Stephen Wood, Amgen
- Kevin Yarasheski, Ph.D., C2N Diagnositcs
- Henrik Zetterberg, M.D., Ph.D., University of Gothenburg